2025 annual financial data

Cullinan Therapeutics 2025 Net margin

Cullinan Therapeutics 2025 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -241,648,000 USD and net income was -219,879,000 USD.
Operating cash flow was -175,750,000 USD.

Get free Cullinan Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-241,648,000 USD
Net income
-219,879,000 USD
Operating cash flow
-175,750,000 USD